Role of lymphadenectomy for ovarian cancer

Japan Society of Gynecologic Oncology (JSGO) recently revised its Ovarian Cancer Treatment Guidelines and the 4th edition will be released next year. This Guidelines state that lymphadenectomy is essential to allow accurate assessment of the clinical stage in early ovarian cancer, but there is no ra...

Descripción completa

Detalles Bibliográficos
Autor principal: Mikami, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195296/
https://www.ncbi.nlm.nih.gov/pubmed/25310033
http://dx.doi.org/10.3802/jgo.2014.25.4.279
_version_ 1782339289625919488
author Mikami, Mikio
author_facet Mikami, Mikio
author_sort Mikami, Mikio
collection PubMed
description Japan Society of Gynecologic Oncology (JSGO) recently revised its Ovarian Cancer Treatment Guidelines and the 4th edition will be released next year. This Guidelines state that lymphadenectomy is essential to allow accurate assessment of the clinical stage in early ovarian cancer, but there is no randomized controlled trial that shows any therapeutic efficacy of lymphadenectomy. In patients with advanced stage tumors, lymphadenectomy should be considered if optimal debulking has been performed. I fully agree with this recommendation of the JSGO and I would like to discuss the role of lymphadenectomy in the management of ovarian cancer.
format Online
Article
Text
id pubmed-4195296
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-41952962014-10-14 Role of lymphadenectomy for ovarian cancer Mikami, Mikio J Gynecol Oncol Expert Opinion Japan Society of Gynecologic Oncology (JSGO) recently revised its Ovarian Cancer Treatment Guidelines and the 4th edition will be released next year. This Guidelines state that lymphadenectomy is essential to allow accurate assessment of the clinical stage in early ovarian cancer, but there is no randomized controlled trial that shows any therapeutic efficacy of lymphadenectomy. In patients with advanced stage tumors, lymphadenectomy should be considered if optimal debulking has been performed. I fully agree with this recommendation of the JSGO and I would like to discuss the role of lymphadenectomy in the management of ovarian cancer. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014-10 2014-10-07 /pmc/articles/PMC4195296/ /pubmed/25310033 http://dx.doi.org/10.3802/jgo.2014.25.4.279 Text en Copyright © 2014. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Expert Opinion
Mikami, Mikio
Role of lymphadenectomy for ovarian cancer
title Role of lymphadenectomy for ovarian cancer
title_full Role of lymphadenectomy for ovarian cancer
title_fullStr Role of lymphadenectomy for ovarian cancer
title_full_unstemmed Role of lymphadenectomy for ovarian cancer
title_short Role of lymphadenectomy for ovarian cancer
title_sort role of lymphadenectomy for ovarian cancer
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195296/
https://www.ncbi.nlm.nih.gov/pubmed/25310033
http://dx.doi.org/10.3802/jgo.2014.25.4.279
work_keys_str_mv AT mikamimikio roleoflymphadenectomyforovariancancer

Ejemplares similares